While there is abundant research reporting high expression of GINS2 in various tumors, including gliomas, promoting tumor cell proliferation and migration, inhibiting apoptosis, and regulating the cell cycle, it can serve as a new diagnostic marker and therapeutic biomarker for tumors [29]. The gene discussed is GINS2; the disease is central nervous system cancer.